TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Closed Christmas Day 12-24 13:00:00 EST

1.11

+0.02

+1.38%

盘后1.11

+0.000.00%

16:23 EST

High1.15	Low1.09	Vol8.54K
Open1.09	D1 Closing1.10	Amplitude5.43%
Mkt Cap12.80M	Tradable Cap10.31M	Total Shares11.53M
T/O9.51K	T/O Rate0.09%	Tradable Shares9.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":1.1101,"timestamp":1735063200000,"preClose":1.095,"halted":0,"volume":8538,"hourTrading":{"tag":"盘后","latestPrice":1.1101,"preClose":1.1101,"latestTime":"16:23 EST","volume":224,"amount":250.2947,"timestamp":1735075407695},"delay":0,"floatShares":9290670,"shares":11532432,"eps":-0.293837,"marketStatus":"Closed Christmas Day","change":0.0151,"latestTime":"12-24 13:00:00 EST","open":1.09,"high":1.1495,"low":1.09,"amount":9509.8521,"amplitude":0.054338,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.293837,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1735203600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":1.095,"postHourTrading":{"tag":"盘后","latestPrice":1.1101,"preClose":1.1101,"latestTime":"16:23 EST","volume":224,"amount":250.2947,"timestamp":1735075407695},"volumeRatio":0.46090906266946674,"impliedVol":0.1041,"impliedVolPercentile":0.0675},"requestUrl":"/m/hq/s/TXMD/wiki","defaultTab":"wiki","newsList":[{"id":"2493714347","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2493714347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493714347?lang=en_us&edition=fundamental","pubTime":"2024-12-24 06:38","pubTimestamp":1734993480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 1.35% to $1.10 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.98% to 19,764.89 and the Dow Jones Industrial Average  rising 0.16% to 42,906.95.TherapeuticsMD Inc. closed $1.66 short of its 52-week high , which the company reached on March 6th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 1.60% to $178.39.Trading volume  eclipsed its 50-day average volume of 20,548.Data source: Dow Jones Market Data, FactSet. Data compiled December 23, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2492438255","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2492438255","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492438255?lang=en_us&edition=fundamental","pubTime":"2024-12-20 06:38","pubTimestamp":1734647880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slumped 0.91% to $1.09 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.04% to 42,342.24 and the NASDAQ Composite Index  falling 0.10% to 19,372.77.This was the stock's fifth consecutive day of losses.TherapeuticsMD Inc. closed $1.66 below its 52-week high , which the company reached on March 6th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  fell 0.87% to $171.52.Trading volume  remained 65 below its 50-day average volume of 18,996.Data source: Dow Jones Market Data, FactSet. Data compiled December 19, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2492294356","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2492294356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492294356?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:28","pubTimestamp":1734388080,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 3.28% to $1.18 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.24% to 20,173.89 and the Dow Jones Industrial Average  falling 0.25% to 43,717.48.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed $1.57 below its 52-week high , which the company achieved on March 6th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  fell 1.00% to $171.63.Trading volume  eclipsed its 50-day average volume of 17,190.Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2491368050","title":"TherapeuticsMD Inc. Stock Remains Steady Thursday, Still Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2491368050","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491368050?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:28","pubTimestamp":1734042480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  were unchanged Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index  falling 0.66% to 19,902.84 and Dow Jones Industrial Average  falling 0.53% to 43,914.12.TherapeuticsMD Inc. closed $1.50 short of its 52-week high , which the company achieved on March 6th.The stock outperformed some of its competitors Thursday, as AbbVie Inc.  fell 0.68% to $173.19.Trading volume  remained 9,227 below its 50-day average volume of 17,467.Data source: Dow Jones Market Data, FactSet. Data compiled December 12, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2490027261","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2490027261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490027261?lang=en_us&edition=fundamental","pubTime":"2024-12-11 06:33","pubTimestamp":1733869980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 3.08% to $1.26 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.25% to 19,687.24 and Dow Jones Industrial Average  falling 0.35% to 44,247.83.TherapeuticsMD Inc. closed $1.49 below its 52-week high , which the company achieved on March 6th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  fell 0.51% to $175.67.Trading volume  remained 11,973 below its 50-day average volume of 17,774.Data source: Dow Jones Market Data, FactSet. Data compiled December 10, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2490708157","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2490708157","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490708157?lang=en_us&edition=fundamental","pubTime":"2024-12-10 06:32","pubTimestamp":1733783520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 5.69% to $1.30 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.62% to 19,736.69 and Dow Jones Industrial Average  falling 0.54% to 44,401.93.The stock's rise snapped a five-day losing streak.TherapeuticsMD Inc. closed $1.45 below its 52-week high , which the company reached on March 6th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  rose 0.22% to $176.57.Trading volume  eclipsed its 50-day average volume of 17,600.Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2489267932","title":"TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2489267932","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489267932?lang=en_us&edition=fundamental","pubTime":"2024-12-07 06:32","pubTimestamp":1733524320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 2.38% to $1.23 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.81% to 19,859.77 and the Dow Jones Industrial Average  falling 0.28% to 44,642.52.This was the stock's fifth consecutive day of losses.TherapeuticsMD Inc. closed $1.52 below its 52-week high , which the company reached on March 6th.The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc.  rose 0.01% to $176.19.Trading volume  remained 65 below its 50-day average volume of 17,717.Data source: Dow Jones Market Data, FactSet. Data compiled December 6, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2489269111","title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2489269111","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489269111?lang=en_us&edition=fundamental","pubTime":"2024-12-05 06:33","pubTimestamp":1733351580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 1.89% to $1.32 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 1.30% to 19,735.12 and the Dow Jones Industrial Average  rising 0.69% to 45,014.04.This was the stock's third consecutive day of losses.TherapeuticsMD Inc. closed $1.43 below its 52-week high , which the company achieved on March 6th.Despite its losses, the stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 2.78% to $176.46.Trading volume  remained 4,547 below its 50-day average volume of 17,712.Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2488984127","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2488984127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488984127?lang=en_us&edition=fundamental","pubTime":"2024-12-03 06:32","pubTimestamp":1733178720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 3.52% to $1.37 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.97% to 19,403.95 and the Dow Jones Industrial Average  falling 0.29% to 44,782.00.The stock's fall snapped a five-day winning streak.TherapeuticsMD Inc. closed $1.38 short of its 52-week high , which the company reached on March 6th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  fell 0.63% to $181.77.Trading volume  eclipsed its 50-day average volume of 17,320.Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2487451539","title":"TherapeuticsMD Inc. Stock Rises Friday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2487451539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487451539?lang=en_us&edition=fundamental","pubTime":"2024-11-30 06:32","pubTimestamp":1732919520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 0.71% higher to $1.42 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.83% to 19,218.17 and the Dow Jones Industrial Average  rising 0.42% to 44,910.65.This was the stock's fifth consecutive day of gains.TherapeuticsMD Inc. closed $1.34 below its 52-week high , which the company reached on December 1st.The stock outperformed some of its competitors Friday, as AbbVie Inc.  fell 0.08% to $182.93.Trading volume  remained 9,744 below its 50-day average volume of 17,509.Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2486385130","title":"TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2486385130","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486385130?lang=en_us&edition=fundamental","pubTime":"2024-11-28 06:32","pubTimestamp":1732746720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 0.71% higher to $1.41 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.60% to 19,060.48 and Dow Jones Industrial Average  falling 0.31% to 44,722.06.This was the stock's fourth consecutive day of gains.TherapeuticsMD Inc. closed $1.58 below its 52-week high , which the company achieved on November 29th.The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc.  rose 1.07% to $183.08.Trading volume  remained 10,838 below its 50-day average volume of 17,531.Data source: Dow Jones Market Data, FactSet. Data compiled November 27, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2486061540","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2486061540","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486061540?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:32","pubTimestamp":1732573920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 1.46% to $1.39 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.27% to 19,054.84 and the Dow Jones Industrial Average  rising 0.99% to 44,736.57.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed $1.60 below its 52-week high , which the company achieved on November 29th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  rose 0.06% to $177.06.Trading volume  eclipsed its 50-day average volume of 17,416.Data source: Dow Jones Market Data, FactSet. Data compiled November 25, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2485224860","title":"TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2485224860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485224860?lang=en_us&edition=fundamental","pubTime":"2024-11-23 06:32","pubTimestamp":1732314720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 3.01% to $1.37 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.16% to 19,003.65 and the Dow Jones Industrial Average  rising 0.97% to 44,296.51.TherapeuticsMD Inc. closed $1.62 short of its 52-week high , which the company achieved on November 24th.The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc.  rose 3.04% to $176.95.Trading volume  eclipsed its 50-day average volume of 17,260.Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2485729811","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2485729811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485729811?lang=en_us&edition=fundamental","pubTime":"2024-11-21 06:32","pubTimestamp":1732141920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 3.08% to $1.34 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.32% to 43,408.47 and the NASDAQ Composite Index  falling 0.11% to 18,966.14.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed $1.65 below its 52-week high , which the company reached on November 24th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  rose 0.71% to $167.76.Trading volume  eclipsed its 50-day average volume of 16,863.Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2484980957","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2484980957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484980957?lang=en_us&edition=fundamental","pubTime":"2024-11-19 06:32","pubTimestamp":1731969120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 7.86% to $1.29 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.60% to 18,791.81 and the Dow Jones Industrial Average  falling 0.13% to 43,389.60.This was the stock's fifth consecutive day of losses.TherapeuticsMD Inc. closed $1.78 below its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 0.78% to $166.28.Trading volume  eclipsed its 50-day average volume of 16,036.Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2483531507","title":"TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2483531507","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483531507?lang=en_us&edition=fundamental","pubTime":"2024-11-16 06:32","pubTimestamp":1731709920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 4.11% to $1.40 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.24% to 18,680.12 and Dow Jones Industrial Average  falling 0.70% to 43,444.99.This was the stock's fourth consecutive day of losses.TherapeuticsMD Inc. closed $1.67 short of its 52-week high , which the company achieved on November 20th.The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc.  fell 2.74% to $164.99.Trading volume  eclipsed its 50-day average volume of 14,264.Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2483321074","title":"TherapeuticsMD Third Quarter 2024 Earnings: US$0.049 loss per share (vs US$0.13 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483321074","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483321074?lang=en_us&edition=fundamental","pubTime":"2024-11-15 19:31","pubTimestamp":1731670296,"startTime":"0","endTime":"0","summary":"NasdaqGS:TXMD Earnings and Revenue History November 15th 2024. All figures shown in the chart above are for the trailing 12 month  period. TherapeuticsMD shares are down 3.9% from a week ago.You still need to take note of risks, for example - TherapeuticsMD has   3 warning signs   we think you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/therapeuticsmd-third-quarter-2024-earnings-113136134.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TXMD"],"gpt_icon":0},{"id":"2483869377","title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2483869377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483869377?lang=en_us&edition=fundamental","pubTime":"2024-11-14 06:32","pubTimestamp":1731537120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  dropped 0.19% to $1.50 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.11% to 43,958.19 and the NASDAQ Composite Index  falling 0.26% to 19,230.73.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed $1.57 below its 52-week high , which the company reached on November 20th.Despite its losses, the stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 0.43% to $170.35.Trading volume  eclipsed its 50-day average volume of 13,586.Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0},{"id":"2483043377","title":"TherapeuticsMD Reports Reduced Losses Amid Strategic Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483043377?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:48","pubTimestamp":1731473320,"startTime":"0","endTime":"0","summary":"Therapeuticsmd Inc ( ($TXMD) ) has released its Q3 earnings. Here is a breakdown of the information Therapeuticsmd Inc presented to its investors. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-reduced-losses-amid-strategic-shift?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-reduced-losses-amid-strategic-shift?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD","BK4007"],"gpt_icon":0},{"id":"2483066157","title":"TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2483066157","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483066157?lang=en_us&edition=fundamental","pubTime":"2024-11-13 06:25","pubTimestamp":1731450349,"startTime":"0","endTime":"0","summary":"TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.05) per share. This is a 61.54 percent increase over losses of $(0.13) per share from the same period last year.  The company reported $547.00 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41923976/therapeuticsmd-q3-eps-0-05-up-from-0-13-yoy-sales-547-00k-up-from-53-00k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TherapeuticsMD Q3 EPS $(0.05) Up From $(0.13) YoY, Sales $547.00K Up From $(53.00K) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therapeuticsmd.com","stockEarnings":[{"period":"1week","weight":-0.0262},{"period":"1month","weight":-0.1897},{"period":"3month","weight":-0.3062},{"period":"6month","weight":-0.362},{"period":"1year","weight":-0.5194},{"period":"ytd","weight":-0.5066}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.028865},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.033479},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.005565},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.0513},{"month":5,"riseRate":0.5,"avgChangeRate":-0.009175},{"month":6,"riseRate":0.583333,"avgChangeRate":0.018393},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.044018},{"month":8,"riseRate":0.5,"avgChangeRate":0.050162},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024766},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.08678},{"month":11,"riseRate":0.583333,"avgChangeRate":0.022841},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.020636}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction